Skip to main content
. Author manuscript; available in PMC: 2008 Aug 1.
Published in final edited form as: Curr Pharm Des. 2004;10(20):2463–2475. doi: 10.2174/1381612043383872

Fig. 3.

Fig. 3

Effects of risperidone (10 μM) on action potential configuration in single canine ventricular myocytes paced a 1 Hz recorded 5 min after the drug superfusion (A). B: Cumulative concentration-dependent effects of risperidone on action potential duration measured at various level of repolarization in canine myocytes (n=5). C: Comparison of the APD prolongation effect of risperidone in canine ventricular myocytes (n=5) and guinea-pig papillary muscles (n=9). The risperidone induced prolongation of APD90 was normalized to control APD90 and expressed as its percent. Solid lines were obtained by fitting the data to the two-state Boltzmann model in order to determine EC50 values.

HHS Vulnerability Disclosure